CA2184545A1 - Traitement du cancer a l'aide de temozolomide - Google Patents

Traitement du cancer a l'aide de temozolomide

Info

Publication number
CA2184545A1
CA2184545A1 CA 2184545 CA2184545A CA2184545A1 CA 2184545 A1 CA2184545 A1 CA 2184545A1 CA 2184545 CA2184545 CA 2184545 CA 2184545 A CA2184545 A CA 2184545A CA 2184545 A1 CA2184545 A1 CA 2184545A1
Authority
CA
Canada
Prior art keywords
temozolomide
administered
period
day
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2184545
Other languages
English (en)
Inventor
Pascale Reidenberg
Margaret H. Dugan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of CA2184545A1 publication Critical patent/CA2184545A1/fr
Abandoned legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CA 2184545 1996-07-31 1996-08-30 Traitement du cancer a l'aide de temozolomide Abandoned CA2184545A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69070796A 1996-07-31 1996-07-31
US08/690,707 1996-07-31

Publications (1)

Publication Number Publication Date
CA2184545A1 true CA2184545A1 (fr) 1998-02-01

Family

ID=24773609

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2184545 Abandoned CA2184545A1 (fr) 1996-07-31 1996-08-30 Traitement du cancer a l'aide de temozolomide

Country Status (2)

Country Link
JP (1) JPH1045589A (fr)
CA (1) CA2184545A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000057867A3 (fr) * 1999-03-30 2001-04-19 Schering Corp Traitement du cancer ameliore avec le temozolomide
US6346524B1 (en) * 1999-03-30 2002-02-12 Schering Corporation Cancer treatment with temozolomide
CN107397735A (zh) * 2017-07-28 2017-11-28 东曜药业有限公司 一种替莫唑胺药物组合物及其制备方法和应用

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20001320A1 (es) * 1998-12-07 2000-12-06 Schering Corp Uso de composiciones microcristalinas de temozolomida en el tratamiento de canceres
US6635677B2 (en) 1999-08-13 2003-10-21 Case Western Reserve University Methoxyamine combinations in the treatment of cancer
US6465448B1 (en) * 1999-08-13 2002-10-15 Case Western Reserve University Methoxyamine potentiation of temozolomide anti-cancer activity
KR20140087846A (ko) * 2012-12-31 2014-07-09 주식회사 삼양바이오팜 테모졸로미드를 포함하는 안정성이 개선된 약제학적 조성물 및 이의 제조방법
WO2017021216A1 (fr) * 2015-07-31 2017-02-09 Inflectis Bioscience Procédé de traitement de cancer avec une combinaison de dérivés de benzylidèneguanidine et d'agent chimiothérapeutique
CN111163776A (zh) 2017-06-12 2020-05-15 安吉奥斯医药品有限公司 使用组合疗法治疗脑肿瘤的方法
MX393477B (es) 2017-06-12 2025-03-24 Servier Lab Combinación de vorasidenib con radiación y/o agentes adicionales para tratar gliomas.

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000057867A3 (fr) * 1999-03-30 2001-04-19 Schering Corp Traitement du cancer ameliore avec le temozolomide
US6346524B1 (en) * 1999-03-30 2002-02-12 Schering Corporation Cancer treatment with temozolomide
AU780892B2 (en) * 1999-03-30 2005-04-21 Merck Sharp & Dohme Corp. Improved cancer treatment with temozolomide
CN107397735A (zh) * 2017-07-28 2017-11-28 东曜药业有限公司 一种替莫唑胺药物组合物及其制备方法和应用

Also Published As

Publication number Publication date
JPH1045589A (ja) 1998-02-17

Similar Documents

Publication Publication Date Title
US5939098A (en) Cancer treatment with temozolomide
USRE46284E1 (en) Method of administrating an anticancer drug containing α, α, α-trifluorothymidine and thymidine phosphorylase inhibitor
JP2007169297A (ja) テモゾロミドを用いる改善された癌処置
US5824346A (en) Combination therapy for advanced cancer
US6346524B1 (en) Cancer treatment with temozolomide
JPH1045589A (ja) テモゾロミドによる改良されたガンの処置
EP1359979B1 (fr) Combinaison anticancereuse de pyrroles substitues et du paclitaxel
EP1251850B1 (fr) Preparation combinee dans la therapie du cancer
US5942247A (en) Method for treating pediatric high grade astrocytoma including brain stem glioma
EP0858341B1 (fr) Therapie d'association pour des cancers avances comprenant le temozolomide et le cisplatine
US20080057032A1 (en) Combination therapy (temozolomide and alpha-ifn) for advanced cancer
AU719074B2 (en) Combination of temozolomide and alpha-IFN for the treatment of advanced cancer
CA2184546A1 (fr) Methode pour le traitement d'asotrocytomes a forte incidence pediatrique, incluant le gliome du tronc cerebral
MXPA96003833A (es) Tratamiento mejorado del cancer con temozolomida
Bodey et al. Clinical evaluation of asaley
MXPA96003834A (es) Metodo para tratar astrocitoma pediatrico de altogrado incluyendo glioma del tronco cerebral
Rubin et al. A phase II study of intravenous 6-thioguanine (NSC-752) in advanced colorectal carcinoma
MXPA01009926A (en) Improved cancer treatment with temozolomide
MXPA98001585A (es) Terapia combinada para el cancer avanzado, que comprende la temozolomida y el cisplatin
WO2004073719A1 (fr) Traitement combine comprenant un derive d'indolopyrrolocarbazole et un autre agent antitumoral
Price et al. An experimentally designed high dose simultaneous combination of a diaminopyrimidine and folinic acid for the treatment of human malignancies

Legal Events

Date Code Title Description
FZDE Dead